Sugi Predict

Sugi Predict / Compounds / SCHEMBL19106376

SCHEMBL19106376

SCHEMBL19106376

c1ccc(-c2cccc(-c3cc(-c4ccc5c(ccc6ccccc65)c4)cc(-c4nc(-c5ccccc5)c5sc6ccccc6c5n4)c3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 6/20 0.38
▸ CYP1A1 P04798 2/20 0.36
▸ CYP1B1 Q16678 2/20 0.36
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ MMP14 P50281 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ PIM1 P11309 2/20 0.34
▸ PIM2 Q9P1W9 2/20 0.34
▸ PIM3 Q86V86 1/20 0.34
▸ TNKS O95271 2/20 0.34
▸ TNKS2 Q9H2K2 2/20 0.34
▸ LIMK2 P53671 2/20 0.34
▸ F9 P00740 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106377 0.99 LIMK1 (0.39) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106354 0.96 MEN1 (0.37) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106348 0.95 CYP1A1 (0.37) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106366 0.94 CYP1A1 (0.34) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106384 0.93 ALOX5 (0.40) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106360 0.93 MEN1 (0.36) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106246 0.91 ADORA2A (0.36) LIMK1CYP1A1CYP1B1MEN1KMT2A
SCHEMBL19106378 0.91 LIMK1 (0.39) LIMK1MEN1KMT2ALMNAMAPT
SCHEMBL19106372 0.91 LIMK1 (0.39) LIMK1MEN1KMT2ALMNAMAPT
SCHEMBL19106374 0.91 LIMK1 (0.39) LIMK1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 LIMK1 591/4885CYP1A1 1209/4885CYP1B1 2433/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 LIMK1 591/4885CYP1A1 1209/4885CYP1B1 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback